Thanks to ⁦The New York Times⁩, the Daily podcast ⁦Michael Barbaro⁩ and ⁦Dan Levin⁩ for this expose about the current wave of anti trans legislation podcasts.apple.com/us/podcast/the…

via New York Times Opinion. Excellent read. My take home: an accident involving release of pandemic causing virus could have happened many places and we should investigate the origins of the current one thoroughly not to punish but to prevent nytimes.com/2021/06/25/opi…

Lee Lab publishes in Science Advance ift.tt/3i2Eqdy ift.tt/2lEpeXu

In this #TWiV Moshe and Ivet discuss their finding that MIS-C after #COVID19 is a consequence of a superantigen in the spike protein of #SARSCoV2 that activates a skewed population of T cell receptor bearing lymphocytes, leading to hyperinflammation bit.ly/3BulY4R

Paper just published in Briefings in Bioinformatics - A protocol for dynamic model calibration ift.tt/3oPOf22 #bioinformatics Great collaboration with AF Villaverde Dilan Pathirana , Jan Hasenauer and @fabfrohlich in the context of the CanPathPro project

My team has just updated our already large database of PhD/Graduate fellowships and graduate student research funding opportunities. We found 200. For each fellowship, we provide link, description, deadline, eligibility, etc. Download here: research.jhu.edu/rdt/funding-op…

To deny gender-affirming resources to trans kids and to threaten their parents and guardians with claims of child abuse is MONSTROUS. If you want to help, support groups like Equality Texas. #protectTransKids

I'm giving a presentation about the best practices for giving scientific presentations. What are your biggest and best presentation tips that you'd pass along to trainees? Please RT!

The Fence Carnegie Mellon University

“Want to promote diversity in science? Offer better support.”nature.com/articles/d4158…

"We argue the lower severity of Omicron is a coincidence and that ongoing rapid antigenic evolution is likely to produce new variants that may escape immunity and be more severe" nature.com/articles/s4157… Peter Markov Aris Katzourakis Nature Reviews Microbiology

Final schedule for upcoming Workshop. If you haven't yet registered, it is too late to be considered for the hands-on "Project Track". But if you want to join for the 3 outstanding Plenary talks (or any other session) please direct message and we'll send you the link.

Congratulations 👏👏👏 to the awardees of this year’s SysMod poster prizes at #ISMB2022 🥁 ➢ 3ʳᵈ: Shaimaa Bakr StanfordEE ➢ 2ⁿᵈ: Kang Jin Cincinnati Children's Biomedical Informatics ➢ 1ˢᵗ: Caroline I. Larkin University of Pittsburgh

bioZone is now officially an award winning YouTube channel 😉 thanks to CPCB for acknowledging our commitment to outreach

Excited to present a rule-based #CellCycle model that explains location and dynamics of 16 observables at #ICSB2022 ! Check out the #SBML, bionetgen and #PEtab model specifications on GitHub (bit.ly/3COdtEM). Feel free to improve/extend model or data with a PR. #sysbio

It’s done!! 🚀🚀🚀🚀 Introducing Addy - Your AI email assistant 🤖 Addy is powered by ChatGPT and can write emails for you 10x faster in your preferred style and tone. If you want early access, please retweet and comment below and I’ll send you an invite code!

So proud of this work lead by CPCB student Neha Cheemalavagu with collaborator Jim Faeder. We systematically identify genes in global transcriptomic data that are predicted by dynamic signaling features and kinase perturbation.

Hi Dale Johnson, is it strange for the AR to be wearing the watch with the GLT signal? On the video you can see her raise her arm in response to the buzzing.

So proud of this paper! It has been a privilege to develop this project with my first PhD student Neha Cheemalavagu, together with Jim Faeder sciencedirect.com/science/articl…

It is clear empirical reality and arguably a fundamental axiom of science that you cannot accurately predict what research will prove to be important in the long run. And yet we continue to pretend that we can, and, what's worse, we put incredibly high stakes on the outcome.